http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2020, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 04 Dec 2020 05:39:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/PharmaEngine%2C+Inc.+and+Sentinel+Oncology+Limited+Enter+into+an+Exclusive+Collaboration+and+License+Agreement+for+SOL-578%2C+a+Chk1+inhibitor/17682414.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine%2C+Inc.+and+Sentinel+Oncology+Limited+Enter+into+an+Exclusive+Collaboration+and+License+Agreement+for+SOL-578%2C+a+Chk1+inhibitor/17682414.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine%2C+Inc.+and+Sentinel+Oncology+Limited+Enter+into+an+Exclusive+Collaboration+and+License+Agreement+for+SOL-578%2C+a+Chk1+inhibitor/17682414.html Fri, 04 Dec 2020 05:39:00 -0500 4162 http://www.streetinsider.com/PRNewswire/PharmaEngine%2C+Inc.+and+Sentinel+Oncology+Limited+Enter+into+an+Exclusive+Collaboration+and+License+Agreement+for+SOL-578%2C+a+Chk1+inhibitor/17682414.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/PharmaEngine%2C+Inc.+and+Sentinel+Oncology+Limited+Enter+into+an+Exclusive+Collaboration+and+License+Agreement+for+SOL-578%2C+a+Chk1+inhibitor/17682414.html for the full story. http://www.streetinsider.com/PRNewswire/PharmaEngine%2C+Inc.+and+Sentinel+Oncology+Limited+Enter+into+an+Exclusive+Collaboration+and+License+Agreement+for+SOL-578%2C+a+Chk1+inhibitor/17682414.html Fri, 04 Dec 2020 05:39:00 -0500 4162 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Thu, 21 Jun 2018 20:07:00 -0500 4162 4162 4162.TW NANO http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Thu, 21 Jun 2018 20:07:00 -0500 4162 4162 4162.TW NANO http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Thu, 21 Jun 2018 20:07:00 -0500 4162 4162 4162.TW NANO http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Positive+Topline+Results+from+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma/14332744.html Thu, 21 Jun 2018 20:07:00 -0500 4162 4162 4162.TW NANO http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html Wed, 19 Oct 2016 11:00:00 -0500 4162 A.06822034 A.31066700 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html Wed, 19 Oct 2016 11:00:00 -0500 4162 A.06822034 A.31066700 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Phase+1b2+Trial+of+PEP503+%28NBTXR3%29+in+Head+and+Neck+Cancer/12146567.html Wed, 19 Oct 2016 11:00:00 -0500 4162 A.06822034 A.31066700 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Onivyde%28R%29+Receives+European+Marketing+Authorization+for+the+Treatment+of+Metastatic+Adenocarcinoma+of+the+Pancreas+Following+Gemcitabine+based+Therapy/12140717.html Tue, 18 Oct 2016 07:47:00 -0500 4162 4162 4162.TWO A.06822034 A.31066700 BXLT MACK SHP SHPG http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Mon, 25 Jul 2016 05:38:00 -0500 4162 4162.TWO A.06822034 A.31066700 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Mon, 25 Jul 2016 05:38:00 -0500 4162 4162.TWO A.06822034 A.31066700 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Mon, 25 Jul 2016 05:38:00 -0500 4162 4162.TWO A.06822034 A.31066700 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+ONIVYDE%28R%29+Regimen+Receives+CHMP+Positive+Opinion+for+the+Treatment+of+Metastatic+Pancreatic+Cancer/11856965.html Mon, 25 Jul 2016 05:38:00 -0500 4162 4162.TWO A.06822034 A.31066700 http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html Tue, 31 May 2016 20:00:00 -0500 4162 4162 4162.TWO A.06822034 NANO http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html Tue, 31 May 2016 20:00:00 -0500 4162 4162 4162.TWO A.06822034 NANO http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html for the full story. http://www.streetinsider.com/Press+Releases/PharmaEngine+Announces+Initiation+of+Global+Pivotal+Trial+of+PEP503+%28NBTXR3%29+in+Soft+Tissue+Sarcoma+in+Asia+Pacific+Region/11693379.html Tue, 31 May 2016 20:00:00 -0500 4162 4162 4162.TWO A.06822034 NANO